1. Home
  2. LIXT vs PLAG Comparison

LIXT vs PLAG Comparison

Compare LIXT & PLAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIXT
  • PLAG
  • Stock Information
  • Founded
  • LIXT 2005
  • PLAG 1986
  • Country
  • LIXT United States
  • PLAG United States
  • Employees
  • LIXT N/A
  • PLAG N/A
  • Industry
  • LIXT Biotechnology: Pharmaceutical Preparations
  • PLAG Packaged Foods
  • Sector
  • LIXT Health Care
  • PLAG Consumer Staples
  • Exchange
  • LIXT Nasdaq
  • PLAG Nasdaq
  • Market Cap
  • LIXT 12.4M
  • PLAG 12.8M
  • IPO Year
  • LIXT N/A
  • PLAG N/A
  • Fundamental
  • Price
  • LIXT $4.47
  • PLAG $1.62
  • Analyst Decision
  • LIXT
  • PLAG
  • Analyst Count
  • LIXT 0
  • PLAG 0
  • Target Price
  • LIXT N/A
  • PLAG N/A
  • AVG Volume (30 Days)
  • LIXT 121.5K
  • PLAG 75.1K
  • Earning Date
  • LIXT 08-07-2025
  • PLAG 08-14-2025
  • Dividend Yield
  • LIXT N/A
  • PLAG N/A
  • EPS Growth
  • LIXT N/A
  • PLAG N/A
  • EPS
  • LIXT N/A
  • PLAG N/A
  • Revenue
  • LIXT N/A
  • PLAG $6,069,007.00
  • Revenue This Year
  • LIXT N/A
  • PLAG N/A
  • Revenue Next Year
  • LIXT N/A
  • PLAG N/A
  • P/E Ratio
  • LIXT N/A
  • PLAG N/A
  • Revenue Growth
  • LIXT N/A
  • PLAG N/A
  • 52 Week Low
  • LIXT $0.64
  • PLAG $0.47
  • 52 Week High
  • LIXT $5.14
  • PLAG $5.52
  • Technical
  • Relative Strength Index (RSI)
  • LIXT 58.29
  • PLAG 46.66
  • Support Level
  • LIXT $3.20
  • PLAG $1.61
  • Resistance Level
  • LIXT $4.60
  • PLAG $1.81
  • Average True Range (ATR)
  • LIXT 0.51
  • PLAG 0.19
  • MACD
  • LIXT 0.06
  • PLAG -0.03
  • Stochastic Oscillator
  • LIXT 78.53
  • PLAG 20.30

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About PLAG Planet Green Holdings Corp.

Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.

Share on Social Networks: